1Smith IC,Heys SD,Hutcheon AW et al,Neoadjuvant chemotherapy in breast cancer:significantly enhanced response with docetaxel.J Clin Oncol,2002;20 (6):1456
2Aventis Pharmaceuticals Inc,Taxotere (docetaxel) injection concertrate regimen shown to provide survival benefits in advanced stomach cancer.http:// www.aventispharma-us.com/ pressrelease/ DisplayPressRelease.do?id = 54081 (June 2,2003)
3Aventis Pharmaceuticals Inc,Investigators report Taxotere offers significant survival benefits for head-and-neck cancer patients.http://www.aventispharma-us.com/pressrelease/DisplayPressRelease.do? id = 61(June 5,2004)
4Vasey PA;Jayson GC;Gordon A et al,Phase Ⅲ randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.J Natl Cancer Inst,2004;96 (22):1682
5MuroK,HamaguchiT,OhtsuA,etal,Aphase Ⅱstudyofsingle-agentdocetaxel in patients with metastatic esophageal cancer.Ann Oncol,2004;15 (6):955
6Fulton B,Spencer CM,Docetaxel.A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer.Drugs,1996;51 (6):1075
8Nabholtz JM,Falkson C,Campos D,et al,Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer:results of a randomized,multicenter,phase Ⅲ trial.J Clin Oncol,.2003;21 (6)::968
9Alba E,Martin M,Ramos M,et al,Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer:a Spanish Breast Cancer Research Group (GEICAM-9903) phase Ⅲ study.J Clin Oncol,2004;22(13):2587
10Roche Group,European Commission approves Herceptin plus Taxotere as first-line therapy in HER2-positive metastatic breast cancer.http://www.roche.com/med-cor-2004-06-22 (June,22,2004)
4Saloustros E, Georgoulias V. Docetaxel in the treatment of advanced non small cell lung cancer [ J ]. Expert Rev ~nti- cancer Ther, 2008,8(8) :1207-1222.
